摘要 |
A novel combination comprising the MEK inhibitor N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo- phenylamino)6,8-dimethyl;-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1 - yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, with a mTOR inhibitor, pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which the inhibition of MEK and/or mTOR is beneficial, e.g. cancer. |
申请人 |
GLAXOSMITHKLINE LLC;GILMER, TONA;KUMAR, RAKESH;LAQUERRE, SYLVIE |
发明人 |
GILMER, TONA;KUMAR, RAKESH;LAQUERRE, SYLVIE |